View on Pubmed.gov 27057428 | View on doi.org 10.1080/2162402...
Expansion of myeloid derived suppressor cells correlates with number of T regulatory cells and disease progression in myelodysplastic syndrome.
- Department of Haematological Medicine; King's College London and King's College Hospital; London, UK; Department of Clinical Science; Faculty of Medicine and Dentistry; University of Bergen; Bergen, Norway.
- Department of Haematological Medicine; King's College London and King's College Hospital ; London, UK.
- Department of Clinical Science; Faculty of Medicine and Dentistry; University of Bergen ; Bergen, Norway.
Abstract
Although the role of CD4 T cells and in particular Tregs and Th17 cells is established in myelodysplastic syndrome(MDS), the contribution of other components of immune system is yet to be elucidated fully. In this study we investigated the number and function of myeloid derived suppressor cells (MDSCs) in fresh peripheral blood and matched bone marrow samples from 42 MDS patients and the potential correlation with risk of disease progression to acute myeloid leukemia (AML). In peripheral blood, very low-/low risk patients had significantly lower median MDSC number (0.16×10/L(0.03-0.40)) compared to intermediate-/high-/very high risk patients, in whom median MDSC counts was 0.52×10/L(0.10-1.78), < 0.005. When co-cultured with CD4+ effector T-cells (T-effectors), MDSCs suppress Teffector proliferation in both allogeneic and autologous settings. There was a positive correlation between the number of Tregs and MDSCs (Spearman R = 0.825, < 0.005) in high risk and not low risk patients. We also investigated MDSCs' expression of bone marrow-homing chemokine receptors, and our data shows that MDSCs from MDS patients express both CXCR4 and CX3CR1 which might facilitate migration of MDSCs to bone marrow. Monocytic MDSCs(M-MDSCs) which are more frequent in the peripheral blood express higher levels of CX3CR1 and CXCR4 than the granulocytic subtype (G-MDSCs), and circulating M-MDSCs had significantly higher CX3CR1 expression compared to bone-marrow M-MDSCs in intermediate-/high-/very high risk MDS. Our results suggest that MDSCs contribute significantly to the dysregulation of immune surveillance in MDS, which is different between low and high risk disease. It further points at mechanisms of MDSCs recruitment and contribution to the bone marrow microenvironment.
References
Cancer Res. 2008 Mar 15;68(6):1715-22
J Immunol Methods. 2001 Dec 1;258(1-2):193-8
J Immunol Methods. 2012 Jul 31;381(1-2):14-22
Blood. 2012 Mar 1;119(9):2033-43
Cited by 112 citations (total)
Journal Article Review
Tissue-specific Role of CXCR1 Expressing Immune Cells and Their Relationships with Human Disease.
Electronic publication date March 6, 2018
Myoungsoo Lee [...] Sun-Young Chang et al.
Chemokine (C-X3-C motif) ligand 1 (CXCL1, also known as fractalkine) and its receptor chemokine (C-X3-C motif) receptor 1 (CXCR1) are...
Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review
IRAK1 and IRAK4 as emerging therapeutic targets in hematologic malignancies.
Electronic publication date January 27, 2022
Joshua Bennett [...] Daniel T Starczynowski et al.
PURPOSE OF REVIEW
Cell intrinsic and extrinsic perturbations to inflammatory signaling pathways are a hallmark of development and progression of hematologic...
Conflict of interest statement
MeSH
- •
- •
- •
- •
- •
- •
- •
Specialties
- •
- •
- •
- •
- •
- •
- •
- •
- •